Public Health & Policy
FDA General
More in FDA General
Final rule is first update to "healthy" nutrient content claim in 30 years
Compounders only have 2 to 3 months left to copy injectable
Response rate of 70% at day 28 with remestemcel-L
In randomized study, ensartinib doubled PFS versus first-generation ALK inhibitor
The warning highlights known risk of rare but serious liver injury associated with fezolinetant
FDA approves tapinarof cream 1% for adults and kids 2 years and up
Crinecerfont reduces excessive adrenal androgen production, lowering glucocorticoid dose
PD-L1 inhibitor indicated for metastatic or locally advanced disease
Nemolizumab indicated for chronic skin disease in adults and kids ages 12 years and up
With a potentially deadly recall, case highlights shortcomings in overseas drug manufacturing
Mostly expired drugs are no longer effective against circulating SARS-CoV-2 strains
A "very complicated situation" after mRNA vaccine trial was halted, expert says
Health news and commentary gathered by 51˶ staff
Obeticholic acid (Ocaliva) may cause serious liver damage even in PBC patients without cirrhosis
